The authors present a review of the techniques commonly used for glycosylation analysis.
Michiel E. Ultee, PhD
Advertisement
Michiel E. Ultee, PhD, was Chief Scientific Officer at Laureate Pharma, Inc.
Articles by Michiel E. Ultee, PhD
Michiel E. Ultee of Laureate Biopharmaceutical Services gives an update on 1988 article regarding virus testing and how the advance of monoclonal antibodies has changed processes.
Formulators and developers are at the heart of the industry's basic premise-they are saving lives.
How to ensure smooth technology transfers.
When platform processes are applied to fusion molecules, innovation and flexibility are needed.
Advertisement
Latest Updated Articles
A 25-Year Retrospective on Bioprocessing mAbsPublished: September 1st 2012 | Updated:
Developing Discoveries into New TherapeuticsPublished: June 1st 2012 | Updated:
Facilitating Technology Transfer to Your CMOPublished: January 1st 2009 | Updated:
Solutions for Purification of Fc-fusion ProteinsPublished: March 2nd 2008 | Updated:
Implications of Cell Culture Conditions on Protein GlycosylationPublished: November 1st 2015 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
